AAAAAA
Results:
1-21
|
Results: 21
Authors:
Merke, DP
Cutler, GB
Citation: Dp. Merke et Gb. Cutler, New ideas for medical treatment of congenital adrenal hyperplasia, END METAB C, 30(1), 2001, pp. 121
Authors:
Feuillan, PP
Jones, JV
Barnes, K
Klein, KO
Cutler, GB
Citation: Pp. Feuillan et al., Follow-up of children and young adults after GnRH-agonist therapy for central precocious puberty, J ENDOC INV, 24(9), 2001, pp. 734-736
Authors:
Feuillan, P
Peters, KF
Cutler, GB
Biesecker, LG
Citation: P. Feuillan et al., Evidence for decreased growth hormone in patients with hypothalamic hamartoma due to Pallister-Hall syndrome, J PED END M, 14(2), 2001, pp. 141-149
Authors:
Leschek, EW
Chan, WY
Diamond, DA
Kaefer, M
Jones, J
Barnes, KM
Cutler, GB
Citation: Ew. Leschek et al., Nodular Leydig cell hyperplasia in a boy with familial male-limited precocious puberty, J PEDIAT, 138(6), 2001, pp. 949-951
Authors:
Leschek, EW
Troendle, JF
Yanovski, JA
Rose, SR
Bernstein, DB
Cutler, GB
Baron, J
Citation: Ew. Leschek et al., Effect of growth hormone treatment on testicular function, puberty, and adrenarche in boys with non-growth hormone-deficient short stature: A randomized, double-blind, placebo-controlled trial, J PEDIAT, 138(3), 2001, pp. 406-410
Authors:
Christiansen, JS
Bengtsson, BA
Thorner, MO
Hintz, R
Sonksen, PH
Cohen, P
Clemmons, D
Strasburger, CJ
Carlsson, L
Tanaka, T
Robinson, I
Jorgensen, JO
Johannson, G
Clayton, PE
Cowell, CT
Malozowski, SN
Hankinson, S
Yee, D
Baxter, R
Swerdlow, A
Rosenfeld, R
Fradkin, JE
Nishi, Y
Monson, JP
van den Berghe, G
Carroll, PV
Takala, J
van der Lely, AJ
Pollak, MN
LeRoith, D
Tachibana, K
Kappelgaard, AM
Langbakke, I
Lippe, B
Wilton, P
Stein, P
Salazar, DE
Maneatis, T
Blethen, SL
Cutler, GB
Blum, WF
Svanberg, E
Gertner, JM
Shimatsu, A
Takahashi, H
Citation: Js. Christiansen et al., Critical evaluation of the safety of recombinant human growth hormone administration: Statement from the growth hormone research society, J CLIN END, 86(5), 2001, pp. 1868-1870
Authors:
Klein, KO
Barnes, KM
Jones, JV
Feuillan, PP
Cutler, GB
Citation: Ko. Klein et al., Increased final height in precocious puberty after long-term treatment with LHRH agonists: The National Institutes of Health Experience, J CLIN END, 86(10), 2001, pp. 4711-4716
Authors:
Rose, SR
Baron, J
Bernstein, D
Yanovski, J
Troendle, JF
Leschek, E
Chipman, J
Cutler, GB
Citation: Sr. Rose et al., Suppression and recovery of GH secretion after GH injection in non-GH deficient short children, J PED END M, 13(3), 2000, pp. 281-288
Authors:
Irony, I
Cutler, GB
Citation: I. Irony et Gb. Cutler, Carbenoxolone effects in congenital adrenal hyperplasia, CLIN ENDOCR, 52(2), 2000, pp. 247-248
Authors:
Seyler, DE
Dodge, JA
Osborne, JJ
Cox, KL
Viswanath, D
Wilmot, AF
Keaton, MJ
Heiman, ML
Bryant, HU
Cutler, GB
Citation: De. Seyler et al., Effect of growth hormone secretagogue LY444711 on IGF-1, growth hormone, and cortisol levels in beagle dog after one and seven daily oral doses, DRUG DEV R, 49(4), 2000, pp. 260-265
Authors:
Ross, JL
Roeltgen, D
Feuillan, P
Kushner, H
Cutler, GB
Citation: Jl. Ross et al., Use of estrogen in young girls with Turner syndrome - Effects on memory, NEUROLOGY, 54(1), 2000, pp. 164-170
Authors:
Merke, DP
Keil, MF
Jones, JV
Fields, J
Hill, S
Cutler, GB
Citation: Dp. Merke et al., Flutamide, testolactone, and reduced hydrocortisone dose maintain normal growth velocity and bone maturation despite elevated androgen levels in children with congenital adrenal hyperplasia, J CLIN END, 85(3), 2000, pp. 1114-1120
Authors:
Mericq, MV
Eggers, M
Avila, A
Cutler, GB
Cassorla, F
Citation: Mv. Mericq et al., Near final height in pubertal growth hormone (GH)-deficient patients treated with GH alone or in combination with luteinizing hormone-releasing hormone analog: Results of a prospective, randomized trial, J CLIN END, 85(2), 2000, pp. 569-573
Authors:
Feuillan, PP
Jones, JV
Barnes, KM
Oerter-Klein, K
Cutler, GB
Citation: Pp. Feuillan et al., Boys with precocious puberty due to hypothalamic hamartoma: Reproductive axis after discontinuation of gonadotropin-releasing hormone analog therapy, J CLIN END, 85(11), 2000, pp. 4036-4038
Authors:
Feuillan, P
Merke, D
Leschek, EW
Cutler, GB
Citation: P. Feuillan et al., Use of aromatase inhibitors in precocious puberty, ENDOCR-R CA, 6(2), 1999, pp. 303-306
Authors:
Avila, NA
Shawker, TS
Jones, JV
Cutler, GB
Merke, DP
Citation: Na. Avila et al., Testicular adrenal rest tissue in congenital adrenal hyperplasia: Serial sonographic and clinical findings, AM J ROENTG, 172(5), 1999, pp. 1235-1238
Authors:
Irony, I
Cutler, GB
Citation: I. Irony et Gb. Cutler, Effect of carbenoxolone on the plasma renin activity and hypothalamic-pituitary-adrenal axis in congenital adrenal hyperplasia due to 21-hydroxylase deficiency, CLIN ENDOCR, 51(3), 1999, pp. 285-291
Authors:
Dorn, LD
Nottelmann, ED
Susman, EJ
Inoff-Germain, G
Cutler, GB
Chrousos, GP
Citation: Ld. Dorn et al., Variability in hormone concentrations and self-reported menstrual histories in young adolescents: Menarche as an integral part of a developmental process, J YOUTH ADO, 28(3), 1999, pp. 283-304
Authors:
Merke, DP
Tajima, T
Baron, J
Cutler, GB
Citation: Dp. Merke et al., Hypogonadotropic hypogonadism in a female caused by an X-linked recessive mutation in the DAX1 gene, N ENG J MED, 340(16), 1999, pp. 1248-1252
Authors:
Feuillan, PP
Jones, JV
Barnes, K
Oerter-Klein, K
Cutler, GB
Citation: Pp. Feuillan et al., Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: Long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precociouspuberty, J CLIN END, 84(1), 1999, pp. 44-49
Authors:
Leschek, EW
Jones, J
Barnes, KM
Hill, SC
Cutler, GB
Citation: Ew. Leschek et al., Six-year results of spironolactone and testolactone treatment of familial male-limited precocious puberty with addition of deslorelin after central puberty onset, J CLIN END, 84(1), 1999, pp. 175-178
Risultati:
1-21
|